Ipsen’s Bylvay fails key trial in children with rare liver disease
Ipsen disclosed that Bylvay failed a Phase 3 study for biliary atresia, a serious liver disease that leads the bile ducts to become blocked in babies. Babies with the disease can get a Kasai procedure ...
Ipsen disclosed that Bylvay failed a Phase 3 study for biliary atresia, a serious liver disease that leads the bile ducts to become blocked in babies.
Babies with the disease can get a Kasai procedure ...
Source: Endpoints News